The #ShortCUT# trial sparked a lot of conversation, but not a change in perspective for Dr. William Dixon. In this new @CardioBusiness article, the Blue Collar I.C. podcast host explains why he remains confident in a #ShockwaveIVL-first# approach and continues to view it as the “gold standard” for calcium modification. 🔗  Dr. William C. Dixon is a paid consultant of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

What difference can better trackability make in the cath lab? ▶️ Watch Prof. Dr. Med. Michael Haude’s testimony on his first experience using #ShockwaveC2Aero#. The improved trackability helped Prof. Haude navigate tighter lesions more easily, while enhanced emitter visibility provided greater confidence throughout the procedure. Additionally, the shortened interval between every ten pulse deliveries, now reduced to just 5 seconds, contributed to a smoother workflow. At Shockwave, we are committed to advancing technologies that support physicians treating calcified lesions. Congratulations to Prof. Dr. Med. Haude on this amazing first case using Shockwave C2 Aero. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #Trackability# Prof. Dr. Med. Michael Haude is a paid consultant for Shockwave Medical. Compared to Shockwave C2+ device. US Rx only. Safety Info:  Product availability may vary by country.

What if you could cross a tight calcified lesion without aggressive pre-dilatation? ▶️ Watch Dr. Gabriele Gasparini share how #ShockwaveC2Aero# supported his procedure, enabling him to start therapy delivery from proximal to distal in a challenging calcified lesion. Thanks to the catheter's crossability and trackability, lesion access was achieved without the need for excessive force, helping facilitate therapy delivery when it mattered most. We are proud to partner with physicians tackling some of the most complex calcified lesions every day. Congratulations to Dr Gasparini on this outstanding results. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #Crossability# Dr Gabriele Gasparini is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

When treating challenging calcified nodules, Shockwave C2 Aero delivers ▶️ Watch Dr Nieves Gonzalo share her experience using #ShockwaveC2Aero# in a patient with a calcified nodule in the ostial and mid LAD. Learn how the device's enhanced crossability and catheter rewrap capability provided the flexibility to navigate the procedure with confidence and re-advance when needed. We're honored to be part of cases that help physicians address complex coronary calcified lesions and advance patient care every day. Congratulations to Dr Gonzalo on this successful treatment. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #CalcifiedNodule# Dr Nieves Gonzalo is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

Our first Global Calcium Academy for Latin American distributor partners brought together 45 territory managers and product specialists from across the region in São Paulo, Brazil. The program focused on advancing knowledge and expertise in calcium modification through: ⭐Understanding the unique mechanism of action of #ShockwaveIVL# ⭐Exploring our comprehensive Coronary and Peripheral portfolio ⭐Reviewing the latest clinical evidence and scientific data ⭐Sharing best practices for Shockwave IVL procedures Huge thank you to Rémy Revol, Eugenia Avila, Elitsa Stoyanova, Laura Bruscia and #ShockNation# leadership for their support. US Rx only. Safety Info:  Product availability may vary by country.

#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.

A Featured Clinical Research session you won't want to miss at #TCT2026#: FORWARD CAD 30-day results. ⚡ Join Dr. Robert W. Yeh (@rwyeh) as he presents new 30-day results from the FORWARD CAD IDE study evaluating Shockwave Javelin Coronary IVL in challenging coronary lesions and discusses the future of this innovative technology. 📅 Sunday, November 1 ⏰ 12:58 PM PT 📍 Coronary Live Case Theater, Ground Level, Halls A-B, San Diego Convention Center Meet us as @JNJMedTech circulatory restoration solutions for the first time and plan your TCT schedule with our featured studies, sessions, and education:  @TCTConference #ShockwaveIVL# #JNJMedTech# Caution: Investigational device. Limited by Federal (U.S) law to investigational use only. Outside the U.S., the device is subject to local regulatory requirements and is not commercially available.

#ShockwaveC2AeroFly# is set for takeoff. ⚡✈️ Don't miss Drs. Yousif Ahmad, Ziad Ali (@ziadalinyc), Emmanouil Brilakis (@esbrilakis), and Rhian Davies (@RhianEDavies1) at #TCT2026# as they discuss complex coronary calcium, the critical clinical evidence behind the Shockwave IVL portfolio, and the next era of treatment with Shockwave C2 Aero Fly. 📅 Monday, November 2 | 12:45–1:45 PM Meet us as @JNJMedTech circulatory restoration solutions for the first time and see what's on board for #TCT#:  @TCTConference #ShockwaveIVL# #JNJMedTech# Presenting physicians are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

For Healthcare Professionals Only: Dziękuję, Poland! What inspiring days of clinical exchange. Last week, our latest device made its debut at the 2nd Kashubian-Pomeranian Interventional Cardiology Workshop, bringing together a highly engaged community of interventional cardiologists. The first clinical use, led by Dr. Michał Hawranek (@HawranekMichal), lays the groundwork for the rapid adoption of next‑generation #ShockwaveIVL# technologies in Poland and further progress in calcium modification. It was a pleasure to connect and exchange valuable perspectives on how this innovation can support daily practice and advance calcium modification. Together, we’re shaping what’s next in calcium treatment. For professional use only. US Rx only. Safety Info: Product availability may vary by country.

#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.